These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

370 related items for PubMed ID: 9888179

  • 1. [Possibilities and limits of ambulatory supportive measures in oncology exemplified by antibiotic therapy of febrile neutropenia].
    Karthaus M, Meran JG, Geissler RG, Böhme A, Jürgens H, Ganser A.
    Wien Med Wochenschr; 1998; 148(18):427-32. PubMed ID: 9888179
    [Abstract] [Full Text] [Related]

  • 2. [Antimicrobial therapy of febrile neutropenia--current developments].
    Karthaus M, Cornely OA, Südhoff T, Meran J.
    Wien Med Wochenschr; 2001; 151(3-4):66-72. PubMed ID: 11789421
    [Abstract] [Full Text] [Related]

  • 3. [Therapy of febrile neutropenia episodes in systemic hematologic illnesses with new once daily ceftriaxone administration].
    Karthaus M, Südhoff T, Fenchel K, Egerer G, Kämpfe D, Ritter J, Franke A, Heil G, Peters G, Jürgens H.
    Wien Med Wochenschr; 1998; 148(21):481-7. PubMed ID: 10048176
    [Abstract] [Full Text] [Related]

  • 4. Ciprofloxacin and amoxicillin as continuation treatment of febrile neutropenia in pediatric cancer patients.
    Park JR, Coughlin J, Hawkins D, Friedman DL, Burns JL, Pendergrass T.
    Med Pediatr Oncol; 2003 Feb; 40(2):93-8. PubMed ID: 12461792
    [Abstract] [Full Text] [Related]

  • 5. A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy.
    Freifeld A, Marchigiani D, Walsh T, Chanock S, Lewis L, Hiemenz J, Hiemenz S, Hicks JE, Gill V, Steinberg SM, Pizzo PA.
    N Engl J Med; 1999 Jul 29; 341(5):305-11. PubMed ID: 10423464
    [Abstract] [Full Text] [Related]

  • 6. Ceftriaxone alone or in Combination with Teicoplanin in the Management of Febrile Episodes in Neutropenic Children and Adolescents with Cancer on an Outpatient Base.
    Preis S, Jürgens H, Friedland C, Oudekotte-David AA, Thomas L, Göbel U.
    Klin Padiatr; 1993 Jul 29; 205(4):295-9. PubMed ID: 8377450
    [Abstract] [Full Text] [Related]

  • 7. Inpatient versus outpatient management of low-risk pediatric febrile neutropenia: measuring parents' and healthcare professionals' preferences.
    Sung L, Feldman BM, Schwamborn G, Paczesny D, Cochrane A, Greenberg ML, Maloney AM, Hendershot EI, Naqvi A, Barrera M, Llewellyn-Thomas HA.
    J Clin Oncol; 2004 Oct 01; 22(19):3922-9. PubMed ID: 15459214
    [Abstract] [Full Text] [Related]

  • 8. Outpatient therapy with oral ofloxacin for patients with low risk neutropenia and fever: a prospective, randomized clinical trial.
    Hidalgo M, Hornedo J, Lumbreras C, Trigo JM, Colomer R, Perea S, Gómez C, Ruiz A, García-Carbonero R, Cortés-Funes H.
    Cancer; 1999 Jan 01; 85(1):213-9. PubMed ID: 9921995
    [Abstract] [Full Text] [Related]

  • 9. Outpatient, sequential, parenteral-oral antibiotic therapy for lower risk febrile neutropenia in children with malignant disease: a single-center, randomized, controlled trial in Argentina.
    Paganini H, Gómez S, Ruvinsky S, Zubizarreta P, Latella A, Fraquelli L, Iturres AS, Casimir L, Debbag R.
    Cancer; 2003 Apr 01; 97(7):1775-80. PubMed ID: 12655535
    [Abstract] [Full Text] [Related]

  • 10. Medical and non-medical barriers to outpatient treatment of fever and neutropenia in children with cancer.
    Quezada G, Sunderland T, Chan KW, Rolston K, Mullen CA.
    Pediatr Blood Cancer; 2007 Mar 01; 48(3):273-7. PubMed ID: 16435377
    [Abstract] [Full Text] [Related]

  • 11. Early hospital discharge versus continued hospitalization in febrile pediatric cancer patients with prolonged neutropenia: A randomized, prospective study.
    Ahmed N, El-Mahallawy HA, Ahmed IA, Nassif S, El-Beshlawy A, El-Haddad A.
    Pediatr Blood Cancer; 2007 Nov 01; 49(6):786-92. PubMed ID: 17366527
    [Abstract] [Full Text] [Related]

  • 12. Outpatient treatment of low-risk neutropenic fever in cancer patients using oral moxifloxacin.
    Chamilos G, Bamias A, Efstathiou E, Zorzou PM, Kastritis E, Kostis E, Papadimitriou C, Dimopoulos MA.
    Cancer; 2005 Jun 15; 103(12):2629-35. PubMed ID: 15856427
    [Abstract] [Full Text] [Related]

  • 13. [Diagnostic procedures and management of Fever in pediatric cancer patients].
    Laws HJ, Ammann RA, Lehrnbecher T.
    Klin Padiatr; 2005 Nov 15; 217 Suppl 1():S9-16. PubMed ID: 16288350
    [Abstract] [Full Text] [Related]

  • 14. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.
    Gauthier M, Chevalier I, Sterescu A, Bergeron S, Brunet S, Taddeo D.
    Pediatrics; 2004 Oct 15; 114(4):e469-76. PubMed ID: 15466073
    [Abstract] [Full Text] [Related]

  • 15. Outpatient oral antibiotics for febrile neutropenic cancer patients using a score predictive for complications.
    Klastersky J, Paesmans M, Georgala A, Muanza F, Plehiers B, Dubreucq L, Lalami Y, Aoun M, Barette M.
    J Clin Oncol; 2006 Sep 01; 24(25):4129-34. PubMed ID: 16943529
    [Abstract] [Full Text] [Related]

  • 16. Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients.
    Mullen CA, Petropoulos D, Roberts WM, Rytting M, Zipf T, Chan KW, Culbert SJ, Danielson M, Jeha SS, Kuttesch JF, Rolston KV.
    Cancer; 1999 Jul 01; 86(1):126-34. PubMed ID: 10391572
    [Abstract] [Full Text] [Related]

  • 17. [Changes in the epidemiology of infections in patients with febrile neutropenia].
    Karthaus M, Carratala J.
    Wien Med Wochenschr; 2001 Jul 01; 151(3-4):47-52. PubMed ID: 11789419
    [Abstract] [Full Text] [Related]

  • 18. Clinical guidelines for the management of neutropenic patients with unexplained fever in Japan: validation by the Japan Febrile Neutropenia Study Group.
    Tamura K.
    Int J Antimicrob Agents; 2005 Dec 01; 26 Suppl 2():S123-7; discussion S133-40. PubMed ID: 16249072
    [Abstract] [Full Text] [Related]

  • 19. Feasibility of withholding antibiotics in selected febrile neutropenic cancer patients.
    Oude Nijhuis C, Kamps WA, Daenen SM, Gietema JA, van der Graaf WT, Groen HJ, Vellenga E, Ten Vergert EM, Vermeulen KM, de Vries-Hospers HG, de Bont ES.
    J Clin Oncol; 2005 Oct 20; 23(30):7437-44. PubMed ID: 16234511
    [Abstract] [Full Text] [Related]

  • 20. [Application of the concepts of evidence-based medicine to the evidence on the treatment of febrile neutropenia].
    Jarque I, Sanz MA.
    Enferm Infecc Microbiol Clin; 1999 Oct 20; 17 Suppl 2():95-102. PubMed ID: 10605194
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.